2020 |
02/04 | 15:00 2020年3月期第3四半期決算短信〔IFRS〕(連結) |
02/04 | 15:00 通期連結業績(IFRS)の修正に関するお知らせ |
01/30 | 4,271 | 4,273 | 4,213 | 4,250 | -1.48% | 3,943,800 | 6兆6995億 | -2.37% |
01/29 | 4,296 | 4,334 | 4,277 | 4,314 | +0.98% | 3,306,600 | 6兆8004億 | -1.1% |
01/28 | 4,262 | 4,296 | 4,250 | 4,272 | -0.58% | 4,327,000 | 6兆7341億 | -2.2% |
01/27 | 4,301 | 4,323 | 4,276 | 4,297 | -1.15% | 3,289,500 | 6兆7736億 | -1.81% |
01/24 | 4,380 | 4,398 | 4,340 | 4,347 | -0.39% | 3,885,100 | 6兆8524億 | -0.8% |
01/23 | 4,395 | 4,396 | 4,363 | 4,364 | -0.98% | 2,677,000 | 6兆8792億 | -0.48% |
01/22 | 17:00 連結子会社(持株会社)の清算に関するお知らせ |
01/22 | 4,403 | 4,425 | 4,396 | 4,407 | -0.32% | 2,776,900 | 6兆9470億 | +0.46% |
01/21 | 4,434 | 4,454 | 4,399 | 4,421 | -0.36% | 2,221,400 | 6兆9690億 | +0.82% |
01/20 | 4,417 | 4,467 | 4,414 | 4,437 | +0.09% | 2,351,300 | 6兆9942億 | +1.19% |
01/17 | 4,406 | 4,438 | 4,388 | 4,433 | +0.61% | 2,716,800 | 6兆9879億 | +1.14% |
01/16 | 4,443 | 4,456 | 4,399 | 4,406 | +0.16% | 3,089,200 | 6兆9454億 | +0.57% |
01/15 | 4,419 | 4,419 | 4,382 | 4,399 | -0.2% | 2,701,700 | 6兆9343億 | +0.39% |
01/14 | 20:00 事業変革の進捗と優先事項の概要について第38回J.P.モルガン・ヘルスケア・カンファレンスにて発表 |
01/14 | 4,435 | 4,435 | 4,380 | 4,408 | +0.66% | 3,567,800 | 6兆9485億 | +0.55% |
01/10 | 4,348 | 4,379 | 4,340 | 4,379 | +0.85% | 2,663,500 | 6兆9028億 | -0.16% |
01/09 | 4,318 | 4,359 | 4,310 | 4,342 | +2.16% | 4,011,300 | 6兆8445億 | -1.09% |
01/08 | 4,273 | 4,297 | 4,217 | 4,250 | -0.91% | 5,522,900 | 6兆6995億 | -3.3% |
01/07 | 4,280 | 4,303 | 4,241 | 4,289 | +0.4% | 3,751,900 | 6兆7609億 | -2.61% |
01/06 | 4,297 | 4,305 | 4,232 | 4,272 | -1.39% | 4,720,600 | 6兆7341億 | -3.17% |
2019 |
12/30 | 4,335 | 4,355 | 4,319 | 4,332 | -0.73% | 2,537,200 | 6兆8287億 | -2.01% |
12/27 | 4,343 | 4,389 | 4,334 | 4,364 | +0.6% | 2,268,500 | 6兆8792億 | -1.36% |
12/26 | 4,344 | 4,344 | 4,325 | 4,338 | -0.21% | 2,148,900 | 6兆8382億 | -2.01% |
12/25 | 4,365 | 4,377 | 4,342 | 4,347 | -0.44% | 1,499,900 | 6兆8524億 | -1.94% |
12/24 | 4,366 | 4,427 | 4,354 | 4,366 | -0.41% | 2,422,500 | 6兆8823億 | -1.67% |
12/23 | 4,380 | 4,402 | 4,334 | 4,384 | -0.48% | 3,347,400 | 6兆9107億 | -1.44% |
12/20 | 4,461 | 4,467 | 4,373 | 4,405 | -1.54% | 5,685,900 | 6兆9438億 | -1.08% |
12/19 | 4,472 | 4,492 | 4,453 | 4,474 | +0.09% | 3,131,200 | 7兆526億 | +0.43% |
12/18 | 4,480 | 4,480 | 4,448 | 4,470 | +0.04% | 2,943,200 | 7兆463億 | +0.43% |
12/17 | 4,447 | 4,468 | 4,427 | 4,468 | +0.68% | 3,461,600 | 7兆431億 | +0.47% |
12/16 | 17:00 2021年満期米ドル建普通社債、2023年満期米ドル建普通社債及び2028年満期米ドル建普通社債のエクスチェンジ・オファーの締め切りと結果に関するお知らせ |
12/16 | 4,426 | 4,449 | 4,411 | 4,438 | +0.27% | 2,524,300 | 6兆9958億 | -0.05% |
12/13 | 4,464 | 4,480 | 4,423 | 4,426 | +0.39% | 5,372,600 | 6兆9769億 | -0.2% |
12/12 | 4,365 | 4,425 | 4,347 | 4,409 | +0.87% | 3,614,700 | 6兆9501億 | -0.54% |
12/11 | 4,417 | 4,417 | 4,352 | 4,371 | -1.15% | 3,218,800 | 6兆8902億 | -1.29% |
12/10 | 4,399 | 4,422 | 4,379 | 4,422 | +1.17% | 3,508,400 | 6兆9706億 | 0% |
12/09 | 4,400 | 4,400 | 4,361 | 4,371 | -0.32% | 3,207,600 | 6兆8902億 | -0.97% |
12/06 | 4,440 | 4,441 | 4,376 | 4,385 | -1.44% | 3,897,600 | 6兆9123億 | -0.32% |
12/05 | 4,466 | 4,486 | 4,442 | 4,449 | +0.43% | 3,374,500 | 7兆132億 | +1.55% |
12/04 | 4,415 | 4,450 | 4,408 | 4,430 | -0.85% | 4,003,900 | 6兆9832億 | +1.65% |
12/03 | 4,436 | 4,519 | 4,432 | 4,468 | -0.51% | 4,020,200 | 7兆431億 | +3.04% |
12/02 | 4,485 | 4,510 | 4,473 | 4,491 | +0.81% | 3,471,800 | 7兆794億 | +4.2% |
11/29 | 17:00 第143期(中間期)事業活動のご報告 |
11/29 | 4,499 | 4,500 | 4,447 | 4,455 | -0.65% | 3,135,800 | 7兆226億 | +3.99% |
11/28 | 4,492 | 4,509 | 4,467 | 4,484 | -0.18% | 2,797,400 | 7兆683億 | +5.28% |
11/27 | 4,510 | 4,517 | 4,488 | 4,492 | +0.38% | 3,208,000 | 7兆809億 | +6.14% |
11/26 | 4,438 | 4,512 | 4,437 | 4,475 | +1.27% | 7,312,000 | 7兆541億 | +6.45% |
11/25 | 4,481 | 4,509 | 4,416 | 4,419 | -0.67% | 3,895,300 | 6兆9659億 | +5.79% |
11/22 | 4,409 | 4,461 | 4,366 | 4,449 | -0.4% | 4,895,900 | 7兆132億 | +7.13% |
11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(6⁄6) |
11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(5⁄6) |
11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(4⁄6) |
11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(3⁄6) |
11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(2⁄6) |
11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(1⁄6) |
11/21 | 4,495 | 4,500 | 4,397 | 4,467 | -1.37% | 6,768,700 | 7兆415億 | +8.19% |
11/20 | 4,530 | 4,543 | 4,512 | 4,529 | -0.72% | 4,303,000 | 7兆1393億 | +10.44% |
11/19 | 4,490 | 4,562 | 4,487 | 4,562 | +1.18% | 7,828,200 | 7兆1913億 | +12.12% |
11/18 | 4,480 | 4,532 | 4,470 | 4,509 | +1.19% | 8,366,000 | 7兆1077億 | +11.77% |
11/15 | 20:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(4⁄4) |
11/15 | 20:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(3⁄4) |
11/15 | 20:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(2⁄4) |
11/15 | 20:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(1⁄4) |
11/15 | 4,434 | 4,481 | 4,407 | 4,456 | +1.92% | 6,700,900 | 7兆242億 | +11.34% |
11/14 | 20:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(4⁄5) |
11/14 | 20:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(3⁄5) |
11/14 | 20:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(2⁄5) |
11/14 | 20:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(1⁄5) |
11/14 | 20:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(5⁄5) |
11/14 | 18:00 2021年満期米ドル建普通社債、2023年満期米ドル建普通社債及び2028年満期米ドル建普通社債のエクスチェンジ・オファーの開始に関するお知らせ |
11/14 | 4,399 | 4,438 | 4,358 | 4,372 | +0.05% | 5,840,500 | 6兆8918億 | +10.1% |
11/13 | 4,307 | 4,382 | 4,275 | 4,370 | +1.56% | 5,678,400 | 6兆8886億 | +10.89% |
11/12 | 4,300 | 4,332 | 4,263 | 4,303 | -0.37% | 3,946,200 | 6兆7830億 | +9.99% |
11/11 | 4,400 | 4,406 | 4,304 | 4,319 | -1.35% | 5,328,300 | 6兆8082億 | +11.11% |
11/08 | 4,320 | 4,390 | 4,309 | 4,378 | +2.34% | 9,588,600 | 6兆9012億 | +13.27% |
11/07 | 4,266 | 4,299 | 4,231 | 4,278 | +1.21% | 6,494,500 | 6兆7436億 | +11.41% |
11/06 | 4,197 | 4,227 | 4,152 | 4,227 | +0.55% | 6,623,300 | 6兆6632億 | +10.74% |
11/05 | 4,070 | 4,213 | 4,061 | 4,204 | +5.1% | 10,314,400 | 6兆6270億 | +10.66% |
11/01 | 3,949 | 4,023 | 3,919 | 4,000 | +1.83% | 7,995,500 | 6兆3054億 | +5.65% |
10/31 | 15:00 通期連結業績(IFRS)の修正に関するお知らせ |
10/31 | 15:00 2020年3月期第2四半期決算短信[IFRS](連結) |
10/31 | 3,940 | 3,950 | 3,909 | 3,928 | +1.05% | 4,576,200 | 6兆1919億 | +3.92% |
10/30 | 3,890 | 3,933 | 3,872 | 3,887 | +0.26% | 8,450,500 | 6兆1272億 | +2.99% |
10/29 | 3,855 | 3,881 | 3,851 | 3,877 | +1.39% | 4,178,500 | 6兆1115億 | +2.84% |
10/28 | 3,843 | 3,843 | 3,812 | 3,824 | -0.31% | 2,474,100 | 6兆279億 | +1.57% |
10/25 | 3,848 | 3,849 | 3,807 | 3,836 | +0.1% | 2,975,400 | 6兆469億 | +1.97% |
10/24 | 3,845 | 3,859 | 3,829 | 3,832 | +0.55% | 3,439,100 | 6兆405億 | +1.91% |
10/23 | 3,821 | 3,827 | 3,773 | 3,811 | +0.37% | 3,436,800 | 6兆74億 | +1.41% |
10/21 | 3,772 | 3,817 | 3,772 | 3,797 | +0.45% | 2,486,800 | 5兆9854億 | +1.12% |
10/18 | 3,813 | 3,825 | 3,765 | 3,780 | -1.28% | 4,189,000 | 5兆9586億 | +0.72% |
10/17 | 3,854 | 3,866 | 3,813 | 3,829 | -0.34% | 4,213,300 | 6兆358億 | +2.19% |
10/16 | 3,849 | 3,871 | 3,820 | 3,842 | +1.48% | 5,468,100 | 6兆563億 | +2.7% |
10/15 | 3,753 | 3,790 | 3,753 | 3,786 | +1.77% | 3,862,800 | 5兆9680億 | +1.37% |
10/11 | 3,721 | 3,735 | 3,692 | 3,720 | +0.9% | 4,158,900 | 5兆8640億 | -0.35% |
10/10 | 3,673 | 3,704 | 3,643 | 3,687 | -0.32% | 3,726,900 | 5兆8120億 | -1.26% |
10/09 | 3,650 | 3,701 | 3,650 | 3,699 | +0.14% | 4,024,300 | 5兆8309億 | -0.94% |
10/08 | 3,638 | 3,719 | 3,632 | 3,694 | +2.02% | 5,598,500 | 5兆8230億 | -1.02% |
10/07 | 3,636 | 3,637 | 3,602 | 3,621 | -0.52% | 4,265,800 | 5兆7079億 | -2.87% |
10/04 | 3,637 | 3,653 | 3,616 | 3,640 | -1.17% | 5,093,200 | 5兆7379億 | -2.23% |
10/03 | 3,714 | 3,728 | 3,661 | 3,683 | -2.28% | 4,035,400 | 5兆8057億 | -0.89% |
10/02 | 3,727 | 3,790 | 3,725 | 3,769 | +0.24% | 2,935,900 | 5兆9412億 | +1.67% |
10/01 | 3,731 | 3,776 | 3,718 | 3,760 | +1.9% | 3,903,300 | 5兆9271億 | +1.79% |
09/30 | 3,740 | 3,756 | 3,687 | 3,690 | -2.38% | 5,708,300 | 5兆8167億 | +0.11% |
09/27 | 3,820 | 3,844 | 3,746 | 3,780 | -2.35% | 7,071,700 | 5兆9586億 | +2.72% |
09/26 | 3,870 | 3,886 | 3,843 | 3,871 | +0.57% | 7,871,900 | 6兆1020億 | +5.48% |
09/25 | 3,820 | 3,877 | 3,817 | 3,849 | +1.83% | 6,546,100 | 6兆673億 | +5.22% |
09/24 | 3,794 | 3,834 | 3,772 | 3,780 | -0.47% | 7,256,500 | 5兆9586億 | +3.68% |
09/20 | 3,759 | 3,814 | 3,744 | 3,798 | +1.09% | 7,566,900 | 5兆9870億 | +4.43% |
09/19 | 3,743 | 3,776 | 3,739 | 3,757 | +0.4% | 4,720,400 | 5兆9223億 | +3.53% |
09/18 | 3,769 | 3,782 | 3,737 | 3,742 | -1.21% | 4,631,000 | 5兆8987億 | +3.23% |
09/17 | 3,780 | 3,797 | 3,757 | 3,788 | +0.05% | 4,598,700 | 5兆9712億 | +4.64% |
09/13 | 3,734 | 3,831 | 3,722 | 3,786 | +1.8% | 8,576,900 | 5兆9680億 | +4.7% |
09/12 | 3,744 | 3,774 | 3,719 | 3,719 | -0.72% | 5,398,800 | 5兆8624億 | +2.96% |
09/11 | 3,650 | 3,747 | 3,642 | 3,746 | +3.22% | 6,027,400 | 5兆9050億 | +3.71% |
09/10 | 3,669 | 3,673 | 3,625 | 3,629 | -1.47% | 5,557,000 | 5兆7205億 | +0.42% |
09/09 | 3,681 | 3,718 | 3,670 | 3,683 | -0.19% | 4,486,100 | 5兆8057億 | +1.74% |
09/06 | 9:30 NATPARA注射剤(副甲状腺ホルモン製剤)の米国における回収について |
09/06 | 3,700 | 3,718 | 3,656 | 3,690 | -1.76% | 5,806,200 | 5兆8167億 | +1.74% |
09/05 | 3,751 | 3,768 | 3,727 | 3,756 | +0.29% | 5,501,800 | 5兆9207億 | +3.3% |
09/04 | 3,704 | 3,766 | 3,699 | 3,745 | +1.6% | 6,115,500 | 5兆9034億 | +3.14% |
09/03 | 3,625 | 3,696 | 3,625 | 3,686 | +1.1% | 3,636,600 | 5兆8104億 | +1.6% |
09/02 | 3,590 | 3,650 | 3,584 | 3,646 | +1.56% | 3,722,800 | 5兆7473億 | +0.55% |
08/30 | 3,509 | 3,590 | 3,496 | 3,590 | +2.57% | 5,646,000 | 5兆6591億 | -1.02% |